Publications

  • 30 Dec 2015"Alternative splicing detection workflow needs a careful combination of sample prep and bioinformatics analysis" Authors: Carrara et al. (UNITO). Correspondence to: Francesca Zolezzi, e-mail: francesca_zolezzi@immunol.a.edu.sq - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: BMC Bioinformatics. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26050971
  • 30 Nov 2015Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up Federico Mosna from Department of Hematology, General Hospital, Treviso, Italy - June 2015 - American Journal of Hematology. Correspondence to: Giovanni Martinelli, MD, Department of Hematology, Ist "LA Seragnoli," University of Bologna, Via Massarenti 9, Bologna, 40138 Italy. E-mail: martg@tin.it Contract grant sponsor: AIL (TREVISO-BOLOGNA), ELN, AIRC, PRIN, FP7 NGS-PTL project. Received for publication: 22 January 2015; Revised: 27 February 2015; Accepted: 2 March 2015 Am. J. Hematol. 90 http://amsacta.unibo.it/4423/
  • 30 Nov 2015"Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia" Ilaria Iacobucci - Institute of Hematology "L. e A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy - current cancer drug targets journal, 2013 September. ACKNOWLEDGMENTS Supported by European LeukemiaNet, AIL, AIRC, Fondazione Del Monte di Bologna e Ravenna, FIRB 2006, Ateneo RFO grants, Programma di Ricerca Regione - Università 2007 - 2009, PRIN 2010-2011, NGS-PTL project, grant agreement number 306242, funded by the EC Sev.
  • 1 Oct 2015"Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients" Elisa Zuffa from "Seràgnoli" Institute of Hematology, Sant'Orsola-Malpighi University Hospital, Bologna, Italy Published: September 05, 2015 by Oncotarget Correspondence to: Cristina Papayannidis, e-mail: cristina.papayannidis@unibo.it Work supported by: ELN, AIL, AIRC, PRIN, progetto Regione-Università 2010-12 (L. Bolondi), FP7 NGS-PTL project.
  • 5 Sep 2015"MicroRNAs in B-cell lymphomas: how a complex biology gets more complex" Authors: Musilova K, Mraz M. Correspondence to: klara.musilova@fnusa.cz - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: Leukemia. 2015 May. http://www.ncbi.nlm.nih.gov/pubmed/25541152
  • 30 Jul 2015"Functional loss of I?B? leads to NF-?B deregulation in aggressive chronic lymphocytic leukemia" Authors: Mansouri L, et al. (MU). Correspondence to: Richard Rosenquist, e-mail: richard.rosenquist@igp.uu.se - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: J Exp Med. 2015 Jun 1. http://www.ncbi.nlm.nih.gov/pubmed/25987724
  • 19 Jul 2015"Deregulation of Genes Related to Iron and Mitochondrial Metabolism in Refractory Anemia with Ring Sideroblasts" Authors: Del Rey M, et al. (FICUS). Correspondence to: Jesús M. Hernández-Rivas, e-mail: jmhr@usal.es - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: PLoS One. 2015 May 8. http://www.ncbi.nlm.nih.gov/pubmed/25955609
  • 5 Jun 2015"Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia" Authors: Malcikova J, et al. (MU). Correspondence to: mtrbusek@fnbrno.cz - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: Leukemia. 2015 Apr. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396398/
  • 14 May 2015"MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL" Authors: Rodríguez-Vicente AE, et al. (FICUS). Correspondence to: Ana E Rodríguez-Vicente, e-mail: anaerv@hotmail.com - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: BMC Cancer. 2015 Apr 8. http://www.ncbi.nlm.nih.gov/pubmed/25880332
  • 22 Apr 2015"Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting" Authors: Sutton LA, et al. (MU). Correspondence to: Richard Rosenquist, e-mail: richard.rosenguist@igp.uu.se - Acknowledgments: FP7-Health-2012-Innovation-1 NGS-PTL Grant no. 306242. Published by: Haematologica. 2015 Mar. http://www.ncbi.nlm.nih.gov/pubmed/25480502